NCT06741553View on ClinicalTrials.gov

Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Alzheimer DiseaseMild Cognitive Impairment (MCI)
Interventions
DRUG

Lecanemab 10 mg/kg

Lecanemab was administered 10mg/kg every two weeks.

Trial Locations (1)

310009

RECRUITING

Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER